EUVIMEDEUVIMED entdecken
Open Access

Measuring Hypothyroidism Disease Control Using a TSH-based “Time-in-range”

Matthew D Ettleson iD, Nikita Thomas, Marcelo Ramirez, Wen Wan, Donald Hedeker, Antonio C Bianco iD, Neda Laiteerapong iD

The Journal of Clinical Endocrinology & Metabolism · 2026

DOI: 10.1210/clinem/dgaf393 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2026. Verfasst von Matthew D Ettleson und 6 weiteren Autor:innen. Beteiligte Einrichtung: Section of Endocrinology, Diabetes, and Metabolism, University of Chicago, Chicago, IL 60637, USA. Hauptthemen laut MEDLINE: Hypothyroidism, Thyrotropin, Thyroxine. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Diabetes Research and Training Center, University of Chicago, National Institute of Diabetes and Digestive and Kidney Disease.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Time-in-range (TIR) using sequential TSH levels during levothyroxine (LT4) treatment could serve as a measure of chronic disease control in hypothyroidism.

Objectives

Primary objectives: (1) develop a method of estimating TIR and (2) determine the impact of patient sociodemographic characteristics on TIR. Secondary objective: investigate the relationship between TIR and time to cardiovascular event.

Methods

The study was conducted using longitudinal clinical data (2016-2022) from a single academic institution. Study participants were ≥18 years old, LT4-treated, and had ≥3 unique TSH levels collected over a minimum of 2 years. For each patient, TIR, time-above-range (TAR) and time-below-range (TBR) were estimated using linear interpolation of log-transformed TSH levels. Fitted linear regression was used to evaluate the relationship between TIR/TAR/TBR and LT4 dose over the study period. Generalized estimating equations were used to model annualized TIR/TAR/TBR with sociodemographic and clinical covariates. Survival analysis was used to characterize the relationship between TIR and occurrence of cardiovascular events.

Results

A total of 2752 LT4-treated patients had a median TIR of 86% over the study enrollment period (median, 3.8 years). For both males and females, LT4 dose was negatively correlated with TIR (R = −0.23 and −0.30, respectively; P < .001 for both). Male sex and Black race were associated with TIR <75% (OR, 1.30; P < .001; OR, 1.37; P < .001). The association between TAR and cardiovascular events approached significance (OR, 1.03 per +10% TAR; P = .078).

Conclusion

We used TIR estimation to identify differences in disease control between sociodemographic groups and the impact of LT4 dose. In future studies, we aim to better characterize the association between TIR and clinically meaningful outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HypothyroidismThyrotropinThyroxineHumansFemaleMaleMiddle AgedLongitudinal StudiesAgedAdultCardiovascular DiseasesTime FactorsFollow-Up StudiesPrognosis

Stichwörter der Autor:innen

hypothyroidismlevothyroxinelongitudinal analysisquality of care

Substanzen

ThyrotropinThyroxine

Autor:innen und Institutionen

  • Section of Endocrinology, Diabetes, and Metabolism, University of Chicago, Chicago, IL 60637, USA.
  • Section of General Internal Medicine, University of Chicago, Chicago, IL 60637, USA.
  • Department of Public Health Sciences, University of Chicago, Chicago, IL 60637, USA.
  • Division of Endocrinology, Department of Internal Medicine, University of Texas Medical Branch, Galveston, TX 77555, USA.

ORCID-Profile: Matthew D Ettleson, Antonio C Bianco, Neda Laiteerapong

Förderung

  • Diabetes Research and Training Center
  • University of Chicago
  • National Institute of Diabetes and Digestive and Kidney Disease
  • Chicago Center for Diabetes Translation Research Enrichment Program
  • NIDDK NIH HHS
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Ettleson, M. D., Thomas, N., Ramirez, M., Wan, W., Hedeker, D., Bianco, A. C., & Laiteerapong, N. (2026). Measuring Hypothyroidism Disease Control Using a TSH-based “Time-in-range”. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgaf393

Vancouver

Ettleson MD, Thomas N, Ramirez M, Wan W, Hedeker D, Bianco AC, et al. Measuring Hypothyroidism Disease Control Using a TSH-based “Time-in-range”. The Journal of Clinical Endocrinology & Metabolism. 2026. doi:10.1210/clinem/dgaf393

BibTeX
@article{Ettleson2026,
  author = {Ettleson, Matthew D and Thomas, Nikita and Ramirez, Marcelo and Wan, Wen and Hedeker, Donald and Bianco, Antonio C and Laiteerapong, Neda},
  title = {Measuring Hypothyroidism Disease Control Using a TSH-based “Time-in-range”},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2026},
  doi = {10.1210/clinem/dgaf393}
}
Kostenlos starten →